Vanguard Health Care Fund Investor Shares
FundVGHCXNASDAQAbout
For over a quarter-century, this actively managed fund has provided investors with an economical way to access a diverse range of companies operating within the global healthcare industry. Its holdings span various segments, including pharmaceutical developers, medical equipment manufacturers, and groundbreaking research institutions. Compared to other healthcare-focused funds, it generally boasts broader international exposure and tends to have a more stable portfolio with less frequent trading. However, a key consideration for investors is its specialized concentration, as all investments are exclusively confined to the healthcare sector. Given that yearly performance can fluctuate considerably, this fund is best suited as a supplementary component within a broader, well-rounded investment portfolio, especially for those with a long-term outlook.
Key Facts
52-Week Range
Performance
Sector Exposure
- Basic Materials0.00%
- Cash & Others0.48%
- Consumer Defensive1.24%
- Financial Services0.01%
- Healthcare98.26%
Top Holdings
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| LLY | Eli Lilly & Co | 9.16% | $3.37B |
| MRK | Merck & Co Inc | 5.83% | $2.14B |
| AZN.L | AstraZeneca PLC | 5.27% | $1.94B |
| JNJ | Johnson & Johnson | 3.46% | $1.27B |
| GSK.L | GSK PLC | 3.40% | $1.25B |
| EW | Edwards Lifesciences Corp | 3.23% | $1.19B |
| UNH | UnitedHealth Group Inc | 2.91% | $1.07B |
| ISRG | Intuitive Surgical Inc | 2.54% | $933.61M |
| DHR | Danaher Corp | 2.50% | $917.00M |
| BSX | Boston Scientific Corp | 2.47% | $907.44M |
| ABT | Abbott Laboratories | 2.31% | $848.06M |
| UCB.BR | UCB SA | 2.27% | $835.55M |
| ARGX.BR | Argenx SE | 2.26% | $831.76M |
| COR | Cencora Inc | 2.02% | $742.58M |
| VRTX | Vertex Pharmaceuticals Inc | 1.98% | $727.23M |
| CVS | CVS Health Corp | 1.91% | $700.72M |
| NOVN.SW | Novartis AG | 1.69% | $620.60M |
| ELV | Elevance Health Inc | 1.50% | $550.20M |
| ALNY | Alnylam Pharmaceuticals Inc | 1.45% | $533.29M |
| HCA | HCA Healthcare Inc | 1.45% | $532.23M |
| REGN | Regeneron Pharmaceuticals Inc | 1.42% | $521.23M |
| CAH | Cardinal Health Inc | 1.38% | $508.19M |
| UTHR | United Therapeutics Corp | 1.38% | $507.44M |
| 4578.T | Otsuka Holdings Co Ltd | 1.30% | $478.39M |
| 4519.T | Chugai Pharmaceutical Co Ltd | 1.29% | $474.62M |